SGLT2 inhibitors
Advertisement
Coronary Heart Disease Risk Factors and Serum Expression Analysis
...
Editor's Note: This content was written by Amit Goyal, MD, a cardiology fellow at the Cleveland Clinic, and co-founder ...
The manufacturers of Jardiance (empagliflozin) accounted that the FDA has granted FastTrack status to the drug for the ...
Dapagliflozin appears safe and effective across different diuretic subgroups of heart failure patients, a new analysis ...
This week's edition features some drug updates: one on SGLT-2 inhibitors in type 2 diabetic patients, and another on ...
The 2019 Heart Failure Society of America Scientific Meeting (HFSA 2019) in Philadelphia has wrapped up. DocWire News ...
This week's edition includes some troubling findings for statins, good things happening with canagliflozin, a new add-on ...
Semaglutide (OZEMPIC) taken weekly as an add-on therapy to sodium-glucose cotransporter-2 (SGLT-2) inhibitors was ...
Canagliflozin, recently approved for the reduction of heart attack and stroke risk in type 2 diabetics with known ...
Subodh Verma, MD, of St. Michael's Hospital and University of Toronto, talks with DocWire News about the EMPA-HEART ...
Stephen D. Wiviott, MD, talks with DocWire News, about the results and implications from the Dapagliflozin Effect on ...
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.